Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-28

Clinical Trial Update: Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey

View source ↗

Summary

A Mayo Clinic trial evaluating how terminology for papillary microcarcinoma influences treatment preferences in thyroid cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Thyroid Cancer | Status: WITHDRAWN